Published in Health Business Week, November 18th, 2005
Cardium Therapeutics and Aries Ventures will be headquartered in San Diego and will continue to trade under the Aries Ventures name and ticker symbol until the completion of its corporate name change to Cardium Therapeutics, Inc. In addition to the merger and equity financing, the company also announced the strategic acquisition of a portfolio of cardiovascular product candidates from Schering AG Germany.
"[This] announcement represents a substantial milestone for our stockholders, and sets the stage for us to pursue our business...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.